BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 22210902)

  • 1. A Novel Method for Assessing the Chaperone Activity of Proteins.
    Hristozova N; Tompa P; Kovacs D
    PLoS One; 2016; 11(8):e0161970. PubMed ID: 27564234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dodecamer assembly of a metazoan AAA
    Gupta A; Lentzsch AM; Siegel A; Yu Z; Chio US; Cheng Y; Shan SO
    Sci Adv; 2023 May; 9(19):eadf5336. PubMed ID: 37163603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefoldin Subunits and Its Associate Partners: Conservations and Specificities in Plants.
    Yang Y; Zhang G; Su M; Shi Q; Chen Q
    Plants (Basel); 2024 Feb; 13(4):. PubMed ID: 38498526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model of the external force field for the protein folding process-the role of prefoldin.
    Roterman I; Stapor K; Konieczny L
    Front Chem; 2024; 12():1342434. PubMed ID: 38595701
    [No Abstract]   [Full Text] [Related]  

  • 5. Highly sensitive detection of a long-COVID-related SNP in LZTFL1 allele with
    Tang Y; Xu M; Luo B; Wang Y; Chen Y; Yu G; Yang G; Gao S; Wang P
    Acta Biochim Biophys Sin (Shanghai); 2024 May; ():. PubMed ID: 38804045
    [No Abstract]   [Full Text] [Related]  

  • 6. A comprehensive analysis of prefoldins and their implication in cancer.
    Herranz-Montoya I; Park S; Djouder N
    iScience; 2021 Nov; 24(11):103273. PubMed ID: 34761191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functions and mechanisms of prefoldin complex and prefoldin-subunits.
    Liang J; Xia L; Oyang L; Lin J; Tan S; Yi P; Han Y; Luo X; Wang H; Tang L; Pan Q; Tian Y; Rao S; Su M; Shi Y; Cao D; Zhou Y; Liao Q
    Cell Biosci; 2020; 10():87. PubMed ID: 32699605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression of chaperones from P. furiosus enhanced the soluble expression of the recombinant hyperthermophilic α-amylase in E. coli.
    Peng S; Chu Z; Lu J; Li D; Wang Y; Yang S; Zhang Y
    Cell Stress Chaperones; 2016 May; 21(3):477-84. PubMed ID: 26862080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of archaeal prefoldin, a co-chaperone of group II chaperonin.
    Ohtaki A; Noguchi K; Yohda M
    Front Biosci (Landmark Ed); 2010 Jan; 15(2):708-17. PubMed ID: 20036841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaperonins: The hunt for the Group II mechanism.
    Bigotti MG; Clarke AR
    Arch Biochem Biophys; 2008 Jun; 474(2):331-9. PubMed ID: 18395510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varied effects of Pyrococcus furiosus prefoldin and P. furiosus chaperonin on the refolding reactions of substrate proteins.
    Hongo K; Itai H; Mizobata T; Kawata Y
    J Biochem; 2012 Apr; 151(4):383-90. PubMed ID: 22210902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitated release of substrate protein from prefoldin by chaperonin.
    Zako T; Iizuka R; Okochi M; Nomura T; Ueno T; Tadakuma H; Yohda M; Funatsu T
    FEBS Lett; 2005 Jul; 579(17):3718-24. PubMed ID: 15967441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrococcus prefoldin stabilizes protein-folding intermediates and transfers them to chaperonins for correct folding.
    Okochi M; Yoshida T; Maruyama T; Kawarabayasi Y; Kikuchi H; Yohda M
    Biochem Biophys Res Commun; 2002 Mar; 291(4):769-74. PubMed ID: 11866431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of Taq DNA polymerase at high temperature by protein folding pathways from a hyperthermophilic archaeon, Pyrococcus furiosus.
    Laksanalamai P; Pavlov AR; Slesarev AI; Robb FT
    Biotechnol Bioeng; 2006 Jan; 93(1):1-5. PubMed ID: 16299772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of prefoldin interaction sites in the hyperthermophilic group II chaperonin and correlations between binding rate and protein transfer rate.
    Zako T; Murase Y; Iizuka R; Yoshida T; Kanzaki T; Ide N; Maeda M; Funatsu T; Yohda M
    J Mol Biol; 2006 Nov; 364(1):110-20. PubMed ID: 17010374
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.